Recent URGN Stock Price | URGN Stock Predictions | |
$14.24 | +170.37% |
$38.50 |
Recent URGN Analyst Ratings Breakdown, Making URGN Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 4 | 4 | 4 | 4 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 1 | 1 | 1 | 1 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.4 | 1.4 | 1.4 | 1.4 |
For the URGN stock predictions from the analysts covering UroGen Pharma Ltd, we have collected all of the individual URGN stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 4 different analysts covering URGN (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since URGN stock predictions may vary widely, another useful metric to consider is the median URGN stock prediction, which represents the price at which half of the analysts
made URGN stock predictions that were higher and half made URGN stock predictions that were lower. This makes for a different take on the URGN stock predictions out there, as compared to average or mean.
And that median across all the individual URGN stock predictions was: $41.0 as of 2024-04-18.
The very highest of the URGN stock predictions for one year price target was $54.0, while the very lowest of the URGN stock predictions in the analyst group was
$18.0 (with a standard deviation of $16.031). Get the latest Zacks research report on URGN — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
NXGN Stock Predictions
PZZA Stock Predictions
EBAY Stock Predictions
ADT Stock Predictions
FSI Stock Predictions
SMTC Stock Predictions
SRC Stock Predictions
STKS Stock Predictions
CBSH Stock Predictions
|
|
Strong Buy (3.60 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |